$4.26 Billion is the total value of PALISADE CAPITAL MANAGEMENT, LP's 385 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AHCO | New | ADAPTHEALTH CORP | $23,682,000 | – | 644,242 | +100.0% | 0.56% | – |
CDMO | New | AVID BIOSERVICES INC | $15,986,000 | – | 876,899 | +100.0% | 0.38% | – |
BLFS | New | BIOLIFE SOLUTIONS INC | $13,648,000 | – | 379,111 | +100.0% | 0.32% | – |
DNMR | New | DANIMER SCIENTIFIC INC | $9,830,000 | – | 260,385 | +100.0% | 0.23% | – |
ROK | New | ROCKWELL AUTOMATION INC | $9,301,000 | – | 35,041 | +100.0% | 0.22% | – |
New | MONGODB INCnote 0.250% 1/1 | $8,928,000 | – | 6,200,000 | +100.0% | 0.21% | – | |
New | GREENBRIER COS INCnote 2.875% 2/0 | $4,101,000 | – | 3,750,000 | +100.0% | 0.10% | – | |
New | VIAVI SOLUTIONS INCnote 1.750% 6/0 | $3,785,000 | – | 3,000,000 | +100.0% | 0.09% | – | |
New | HALOZYME THERAPEUTICS INCnote 1.250%12/0 | $3,676,000 | – | 2,000,000 | +100.0% | 0.09% | – | |
New | NUVASIVE INCnote 0.375% 3/1 | $3,561,000 | – | 3,475,000 | +100.0% | 0.08% | – | |
New | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $3,492,000 | – | 2,096,000 | +100.0% | 0.08% | – | |
New | BLACKSTONE MTG TR INCnote 4.375% 5/0 | $3,442,000 | – | 3,354,000 | +100.0% | 0.08% | – | |
New | ALLSCRIPTS HEALTHCARE SOLUTNnote 0.875% 1/0 | $3,404,000 | – | 2,575,000 | +100.0% | 0.08% | – | |
New | TABULA RASA HEALTHCARE INCnote 1.750% 2/1 | $2,853,000 | – | 2,825,000 | +100.0% | 0.07% | – | |
New | BANDWIDTH INCnote 0.250% 3/0 | $2,504,000 | – | 1,634,000 | +100.0% | 0.06% | – | |
New | DISH NETWORK CORPORATIONnote 2.375% 3/1 | $2,235,000 | – | 2,320,000 | +100.0% | 0.05% | – | |
New | ENCORE CAP EUROPE FIN LTDnote 4.500% 9/0 | $1,956,000 | – | 1,700,000 | +100.0% | 0.05% | – | |
New | KKR REAL ESTATE FIN TR INCnote 6.125% 5/1 | $1,958,000 | – | 1,901,000 | +100.0% | 0.05% | – | |
New | ENVESTNET INCnote 1.750% 6/0 | $1,720,000 | – | 1,400,000 | +100.0% | 0.04% | – | |
New | INTEGRA LIFESCIENCES HLDGS Cnote 0.500% 8/1 | $1,679,000 | – | 1,500,000 | +100.0% | 0.04% | – | |
New | PEGASYSTEMS INCnote 0.750% 3/0 | $1,360,000 | – | 1,231,000 | +100.0% | 0.03% | – | |
New | BENEFITFOCUS INCnote 1.250%12/1 | $923,000 | – | 995,000 | +100.0% | 0.02% | – | |
SEDG | New | SOLAREDGE TECHNOLOGIES INC | $747,000 | – | 2,600 | +100.0% | 0.02% | – |
QDEL | New | QUIDEL CORP | $601,000 | – | 4,700 | +100.0% | 0.01% | – |
GNRC | New | GENERAC HLDGS INC | $524,000 | – | 1,600 | +100.0% | 0.01% | – |
Z | New | ZILLOW GROUP INCcl c cap stk | $421,000 | – | 3,250 | +100.0% | 0.01% | – |
MAR | New | MARRIOTT INTL INC NEWcl a | $385,000 | – | 2,600 | +100.0% | 0.01% | – |
MITK | New | MITEK SYS INC | $277,000 | – | 19,000 | +100.0% | 0.01% | – |
TTWO | New | TAKE-TWO INTERACTIVE SOFTWAR | $309,000 | – | 1,750 | +100.0% | 0.01% | – |
BMRN | New | BIOMARIN PHARMACEUTICAL INC | $264,000 | – | 3,500 | +100.0% | 0.01% | – |
New | NEOGENOMICS INCnote 0.250% 1/1 | $257,000 | – | 250,000 | +100.0% | 0.01% | – | |
ACN | New | ACCENTURE PLC IRELAND | $235,000 | – | 852 | +100.0% | 0.01% | – |
NICE | New | NICE LTDsponsored adr | $267,000 | – | 1,225 | +100.0% | 0.01% | – |
NOW | New | SERVICENOW INC | $200,000 | – | 400 | +100.0% | 0.01% | – |
CHKP | New | CHECK POINT SOFTWARE TECH LTord | $224,000 | – | 2,000 | +100.0% | 0.01% | – |
ICLN | New | ISHARES TRgl clean ene etf | $202,000 | – | 8,300 | +100.0% | 0.01% | – |
XL | New | XL FLEET CORP | $164,000 | – | 18,250 | +100.0% | 0.00% | – |
New | BLACKROCK TCP CAPITAL CORPnote 4.625% 3/0 | $102,000 | – | 100,000 | +100.0% | 0.00% | – | |
New | THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $102,000 | – | 100,000 | +100.0% | 0.00% | – | |
MNKD | New | MANNKIND CORP | $51,000 | – | 13,000 | +100.0% | 0.00% | – |
New | SUPERNUS PHARMACEUTICALS INCnote 0.625% 4/0 | $14,000 | – | 15,000 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
RAYMOND JAMES FINL INC | 44 | Q3 2023 | 2.1% |
APPLIED INDL TECHNOLOGIES IN | 44 | Q3 2023 | 2.4% |
IDACORP INC | 44 | Q3 2023 | 1.6% |
APPLE INC | 44 | Q3 2023 | 1.7% |
LKQ CORP | 44 | Q3 2023 | 1.6% |
HEICO CORP NEW | 44 | Q3 2023 | 1.3% |
DANAHER CORPORATION | 44 | Q3 2023 | 1.4% |
SEMTECH CORP | 44 | Q3 2023 | 1.2% |
ACI WORLDWIDE INC | 44 | Q3 2023 | 1.3% |
WILEY JOHN & SONS INC | 44 | Q3 2023 | 1.2% |
View PALISADE CAPITAL MANAGEMENT, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
INTRICON CORP | March 03, 2022 | 987 | 0.0% |
BIO REFERENCE LABORATORIES INC | February 08, 2013 | 580,502 | 2.1% |
COMPUTER PROGRAMS & SYSTEMS INC | November 12, 2010 | 41,900 | 0.4% |
MEDICAL ACTION INDUSTRIES INC | February 11, 2009 | 767,000 | 4.8% |
MONMOUTH REAL ESTATE INVESTMENT CORP | February 11, 2008 | 300,000 | 1.2% |
REFAC OPTICAL GROUP | April 26, 2007 | 16,273,698 | 91.4% |
GENESEE & WYOMING INC | February 13, 2007 | 1,707,000 | 4.6% |
SIZELER PROPERTY INVESTORS INC | February 13, 2006 | 62,000 | 0.3% |
OPTICARE HEALTH SYSTEMS INC | September 08, 2005 | 93,258,838 | 84.3% |
MOBILITY ELECTRONICS INC | May 17, 2005 | 1,134,000 | 4.0% |
View PALISADE CAPITAL MANAGEMENT, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-04-16 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-02 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-08 |
13F-HR/A | 2023-03-24 |
13F-HR | 2023-02-14 |
SC 13G/A | 2023-02-13 |
13F-HR | 2022-11-14 |
View PALISADE CAPITAL MANAGEMENT, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.